[Expert Solution]: Case Study 2: Managing Anxiety Disorders…

Case Study 2: Managing Anxiety Disorders with Medication Scenario: Lisa Green, a 27-year-old graduate student, was recently diagnosed with generalized anxiety disorder (GAD) after experiencing persistent worry, muscle tension, difficulty concentrating, and occasional panic episodes that interfered with her academic performance. Her provider prescribed alprazolam (Xanax) 0.5 mg twice daily as needed to help manage acute anxiety symptoms. At her two-week follow-up appointment, Lisa reports that while the medication helps her feel calmer, she has been experiencing daytime drowsiness, dizziness, and episodes of lightheadedness, particularly while driving. She recalls an incident where she nearly fell asleep at the wheel, making her question whether it is safe to continue taking the medication. Further discussion reveals that Lisa occasionally drinks wine in the evenings to unwind after a stressful day. She was unaware that alcohol interacts with her medication and is now concerned about potential side effects and risks. Additionally, Lisa expresses fears of developing dependence on alprazolam. She has read that benzodiazepines carry a risk of addiction, and she does not want to become reliant on the medication long-term. She inquires about alternative pharmacologic treatments that might be safer for ongoing anxiety management. Her nurse notes that Lisa has never been prescribed SSRIs or SNRIs, which are commonly used for chronic anxiety disorders. She also has not had a medication review in over a year, making it necessary to evaluate whether alprazolam is the best long-term option for her condition. Discussion Questions: 1. Considering Lisa’s lifestyle and medication effects, what are the long-term risks of benzodiazepine use? How would you assess whether an alternative treatment might be appropriate? 2. If Lisa decides to discontinue alprazolam, outline a safe tapering schedule and the necessary nursing interventions to prevent withdrawal effects. 3. Develop a comprehensive care plan incorporating non-pharmacological interventions for managing Lisa’s anxiety while reducing her reliance on benzodiazepines.